|
|
||||||||||||||
|
|
|||||||||||||||
a Department of
Autoimmunology, Statens Serum Institute, DK-2300 Copenhagen S, Denmark, b Department of
Health and Environment, Division of Rheumatology, Faculty of Health
Sciences, Linköping University, S-581 85 Linköping, Sweden
Correspondence to: Dr Henning Locht, Department of Autoimmunology, Building 81, Room 524, Statens Serum Institute, DK-2300 Copenhagen S, Denmark Email: hlo{at}ssi.dk
Accepted for publication 10 April 2000
OBJECTIVE
To study the
frequency and distribution of antineutrophil cytoplasmic autoantibodies
(ANCA) among patients with reactive arthritis (ReA), rheumatoid
arthritis (RA), and ulcerative colitis (UC) using different
immunological methods.
METHODS
Fifty serum
samples from patients with reactive arthritis (26 with acute disease
and 24 with chronic disease
that is disease of more than one year)
were analysed for ANCA with indirect immunofluorescence, enzyme
linked immunosorbent assay (ELISA) with six different neutrophil granule proteins as antigens, and immunoblotting on whole neutrophil extract and extracts of azurophil and specific granules. Thirty serum
samples from patients with RA and UC served as controls in ELISA and
indirect immunofluorescence.
RESULTS
Sixteen per
cent of patients with ReA were positive in immunofluorescence compared
with 30% of patients with RA, and 70% of patients with UC. Thirty two
per cent of patients with ReA were positive in ELISA. Antibodies
directed against lactoferrin occurred in 20%, antibodies against
bactericidal permeability increasing protein (BPI), elastase, cathepsin
G, myeloperoxidase, and proteinase 3 were found in 8%, 2%, 2%, 8%,
and 6%, respectively. Overall, 50% of RA sera and 53% of UC sera
were positive in one or more ELISA assays, the corresponding figures
for antibodies against individual antigens were for RA 7%, 3%, 0%,
13%, 47%, 17% and for UC 13%, 20%, 0%, 23%, 10%, and 17%. In
immunoblotting, bands corresponding to lactoferrin and BPI were
recognised in 44% and 22% of ReA sera.
CONCLUSION
Antibodies
against neutrophil granule antigens are often found in patients
with ReA, primarily among those with chronic disease. The different
methods detect various subsets of antibodies, with immunoblotting being
the most and immunofluorescence the least sensitive.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |